REGN

Regeneron Pharmaceuticals, Inc.

Health Care
61
/100
HOLD
Signal 2.0 composite score — 7-pillar quant rating updated daily.

Signal 2.0

7-Pillar Score Breakdown

Each pillar scores 0–100. The composite is a regime-weighted blend of all seven.

Fundamentals & Quality
54
Valuation
71
Technicals & Momentum
53
Sentiment & News
78
Earnings Quality
46
Risk Profile
73
Market Regime
67

Premium Insights

Deeper Analysis — Unlocking Soon

Advanced institutional-grade signals are coming to Quantex Premium. Join the waitlist for early access.

Institutional Flow Signal ★ PREMIUM
🔒 PREMIUM Unlock with Premium
Earnings Risk Score ★ PREMIUM
73
Risk Score / 100
MODERATE
EPS Beat Est.
Report in ~14 days
🔒 PREMIUM Unlock with Premium

Fundamentals

Key Metrics

Sourced from the daily universe scan. Open the terminal for the full financial deep-dive.

Market Cap
$86.8B
P/E Ratio
21.1x
Revenue Growth
+11.2%
EPS Growth
-4.5%
Profit Margin
27.9%
Dividend Yield
0.44%
Beta
0.19

See the full picture for REGN.

Run live Signal 2.0 scoring, deep financial statements, DCF valuation, CAPM, and options pricing — free, no account required.

Open Full Analysis → Browse All Stocks